The short version
4 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Posaconazole
Posaconazole · POSACONAZOLE 18 mg/mL · Solution · Intravenous · Camber Pharmaceuticals, Inc.
NDC 31722-0370-31 · 1 VIAL, GLASS in 1 CARTON / 16.7 mL in 1 VIAL, GLASS · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$270.00
Reported to Texas DSHS · 2026 annual filing · Hetero Labs Limited
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 2 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $1,171.66 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA219057
- TE code
- AP
- Approval date
- Dec 23, 2024
- Patents / exclusivity
- None on file
Shortage history
- Planned discontinuation — Noxafil, Injection, 18 mg/1 mL (NDC 0085-4331-01)Dec 2, 2025
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Posaconazole (Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Camber Pharmaceuticals, Inc. | POSACONAZOLE 18 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| FAREVA Mirabel | POSACONAZOLE 18 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Merck Sharp & Dohme LLC | POSACONAZOLE 18 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Mylan Institutional LLC | POSACONAZOLE 18 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Posaconazole — NDC 31722-0370-31," retrieved September 3, 2026, https://drugdashboards.com/drug/31722037031.
Free to cite with attribution — see how the data is put together.